EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

AstraZeneca buys EsoBiotec in $1bn cell therapy deal

AstraZeneca has announced a $1bn agreement to acquire EsoBiotec, a Belgian biotech firm pioneering in vivo cell therapies.
Woman's hand holding pill

Daily pill for endometriosis to be offered by NHS

The NICE has approved the first daily oral treatment for endometriosis symptoms for use within the NHS in England.
Cartoon brain on green background

Phase 2 trial begins for psychedelic-based depression treatment

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.
Hand with vaccine

UK Chikungunya vaccine approval in sight for Bavarian Nordic

The UK MHRA has validated Bavarian Nordics’ marketing authorisation application for its single-dose chikungunya vaccine.
Handshake on a green background

Jazz Pharmaceuticals to acquire Chimerix in $935m deal

In a deal worth approximately $935m, Jazz Pharmaceuticals is set to acquire Chimerix, a biotechnology company developing oncology therapies.
The word spotlight on a blue background

Spotlight: February 2025

From a historic vaccine approval to a $50bn investment reshaping US drug manufacturing, February brought major pharma news to the fore.

UK's NHS must boost medicine spending, ABPI warns

The UK must increase investment in innovative medicines and vaccines if it is to deliver on the NHS 10-Year Plan and drive economic growth.
White House

Trump administration cuts more than 90% of USAID funding

The Trump administration is set to cut a total of $60bn in US assistance worldwide, signalling a major shift in health policy.
We’ve noticed you’re accessing
from North/South America.